Literature DB >> 9291734

AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD.

M K Dulcan, R S Benson.   

Abstract

This summary of the practice parameters describes the assessment, differential diagnosis, and treatment of children, adolescents, and adults who present with symptoms of attention-deficit/hyperactivity disorder. The rationales for specific recommendations are based on a review of the scientific literature and clinical consensus which is contained in the complete document. Assessment includes clinical interviews with the child and parents and standardized rating scales from parent and teachers. Testing of intelligence and academic achievement is usually required. Comorbidity is common. The cornerstones of treatment are support and education of parents, appropriate school placement, and psychopharmacology. The primary medications are psychostimulants, but antidepressants and alpha-adrenergic agonists are used in special circumstances. Other treatments such as behavior modification, school consultation, family therapy, and group therapy address remaining symptoms.

Entities:  

Mesh:

Year:  1997        PMID: 9291734     DOI: 10.1097/00004583-199709000-00033

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  19 in total

Review 1.  Methylphenidate in the treatment of children with attention-deficit hyperactivity disorder.

Authors:  B Vitiello
Journal:  CMAJ       Date:  2001-11-27       Impact factor: 8.262

Review 2.  ADHD treatments, sleep, and sleep problems: complex associations.

Authors:  Mark A Stein; Margaret Weiss; Laura Hlavaty
Journal:  Neurotherapeutics       Date:  2012-07       Impact factor: 7.620

Review 3.  Personal paper: attention deficit hyperactivity disorder is underdiagnosed and undertreated in Britain.

Authors:  G D Kewley
Journal:  BMJ       Date:  1998-05-23

Review 4.  Assessment and management of attention-deficit hyperactivity disorder in adults.

Authors:  Margaret Weiss; Candice Murray
Journal:  CMAJ       Date:  2003-03-18       Impact factor: 8.262

5.  Pharmacologic intervention for attention-deficit hyperactivity disorder in preschoolers : is it justified?

Authors:  Jaswinder K Ghuman; Harinder S Ghuman
Journal:  Paediatr Drugs       Date:  2013-02       Impact factor: 3.022

6.  The effects of patient characteristics on ADHD diagnosis and treatment: a factorial study of family physicians.

Authors:  Christopher P Morley
Journal:  BMC Fam Pract       Date:  2010-02-08       Impact factor: 2.497

7.  Utility of objective measures of activity and attention in the assessment of therapeutic response to stimulants in children with attention-deficit/hyperactivity disorder.

Authors:  Martin H Teicher; Ann Polcari; Cynthia E McGreenery
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-06       Impact factor: 2.576

Review 8.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Longitudinal mental health service and medication use for ADHD among Puerto Rican youth in two contexts.

Authors:  Hector R Bird; Patrick E Shrout; Cristiane S Duarte; Sa Shen; José J Bauermeister; Glorisa Canino
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-08       Impact factor: 8.829

Review 10.  Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice.

Authors:  Jaswinder K Ghuman; L Eugene Arnold; Bruno J Anthony
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-10       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.